Together Pharma Ltd (TLV:TGTR)

Israel · Delayed Price · Currency is ILS · Price in ILA

210.00

+3.30 (1.60%)

Sep 3, 2026, 10:26 AM IDT

Together Pharma Financials Overview

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	99.94	109.63	96.05	91.01	31.23	12.03
Revenue Growth	-8.84%	14.13%	5.55%	191.42%	159.67%	7.16%
Gross Profit	27.41	31.49	17.51	34.62	-5.89	-2.17
Operating Income	10.38	15.23	3.27	22.09	-19.77	-11.46
Net Income	-0.51	1.91	-1.17	-4.32	-33.52	-13.78
Earnings Per Share	-0.03	0.12	-0.09	-0.49	-4.18	-2.23
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Israel	104.27	104.27	88.55	84.84	27.99	11.23
Europe	1.08	1.08	0.89	0.33	1.94	0.03
Uganda	4.28	4.28	6.62	5.84	1.3	0.77
Total	109.63	109.63	96.05	91.01	31.23	12.03

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	5.45	12.22	8.44	3.59	5.3	5.1
Total Debt	63.36	59.75	63.57	54.8	60.08	85.37
Net Cash (Debt)	-57.9	-47.53	-55.12	-51.21	-54.78	-80.27
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.34	-3.01	-4.44	-5.83	-6.72	-11.72

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-7.67	6.58	2.85	14.83	-13.73	-18.64
Capital Expenditures	-1.65	-1.41	-1.48	-0.87	-0.33	-1.53
Free Cash Flow	-9.31	5.17	1.37	13.97	-14.07	-20.17
Free Cash Flow Growth	-	275.98%	-90.16%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	27.43%	28.72%	18.23%	38.04%	-18.86%	-18.07%
Operating Margin	10.38%	13.89%	3.41%	24.28%	-63.30%	-95.27%
Pretax Margin	-0.28%	4.45%	-2.30%	1.69%	-116.33%	-125.69%
Profit Margin	-0.51%	1.74%	-1.22%	-4.74%	-107.35%	-114.55%
FCF Margin	-9.32%	4.71%	1.43%	15.35%	-45.04%	-167.75%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	30.38	-	-	-	-
P/FCF Ratio	-	11.25	39.38	2.44	-	-
PS Ratio	0.36	0.53	0.56	0.38	0.60	5.65